Metropolis Healthcare enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


10,781	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
195	195	109	116	81.9
11.4	11.4	3.7	3.1	2.5
18.7	18.7	14.2	0.0	79.1
10,616	—	—	—	—
−177	−177	−94.5	−116	−2.8
₹512.03	—	—	—	—

1,543	1,543	1,349	1,099	1,070
1.2%	1.2%	1.1%	0.0%	7.4%
0.00×	—	—	—	—

6.21×	—	—	—	—
25.14×	—	—	—	—
36.99×	—	—	—	—
35.44×	—	—	—	—
1,710	1,646	1,331	1,208	1,148
422	401	303	283	288
287	267	194	188	199
—	351	263	264	247
300	300	194	200	194
—	293	194	199	188
—	51.2	68.6	63.8	52.6

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

METROPOLIS₹520.00

Metropolis Healthcare Ltd.

· Pharma & Health

₹ CrorePeersLALPATHLAB VIJAYA THYROCARE MARKSANS PARKHOSPS JLHL RUBICON HCGMcap ₹10,781 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	10,781.1
- Cash, Equiv & ST Investments	81.9	115.7	108.7	195.4	195.4
+ Minority Interest	2.5	3.1	3.7	11.4	11.4
+ Total Debt	79.1	0.0	14.2	18.7	18.7
Enterprise Value	—	—	—	—	10,615.8
Net Debt (memo)	-2.8	-115.7	-94.5	-176.7	-176.7
EV per Share	—	—	—	—	512.03

Total Capital	1,069.8	1,099.3	1,348.8	1,543.3	1,543.3
Total Debt/Total Capital	7.39	0.00	1.05	1.21	1.21
Total Debt/EV	—	—	—	—	0.00

EV/Sales	—	—	—	—	6.21
EV/EBITDA	—	—	—	—	25.14
EV/EBIT	—	—	—	—	36.99
EV/Free Cash Flow	—	—	—	—	35.44
Reference Items — Trailing FY Values
Sales	1,148.2	1,207.7	1,331.2	1,645.8	1,710.0
EBITDA	288.3	282.6	303.0	400.8	422.3
EBIT	199.1	188.1	194.3	267.1	287.0
Operating Cash Flow	247.1	264.1	262.7	350.7	—
Free Cash Flow	194.5	200.3	194.1	299.5	299.5
FCFF (free cash flow to the firm)	188.0	199.3	194.1	293.1	—
Capital Expenditure	52.6	63.8	68.6	51.2	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.